General Information of Drug (ID: DMZSL7H)

Drug Name
1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone
Synonyms CHEMBL244631; 1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 320.19
Logarithm of the Partition Coefficient (xlogp) 3.3
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 8
Chemical Identifiers
Formula
C14H6F6O2
IUPAC Name
2-hydroxy-1,2-bis(2,3,4-trifluorophenyl)ethanone
Canonical SMILES
C1=CC(=C(C(=C1C(C(=O)C2=C(C(=C(C=C2)F)F)F)O)F)F)F
InChI
InChI=1S/C14H6F6O2/c15-7-3-1-5(9(17)11(7)19)13(21)14(22)6-2-4-8(16)12(20)10(6)18/h1-4,13,21H
InChIKey
ICSVRGYUGLAIDB-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
16745302
TTD ID
D06GYH

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Liver carboxylesterase (CES1) TTMF541 EST1_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Liver carboxylesterase (CES1) DTT CES1 3.82E-08 1.86 1.9
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils. Bioorg Med Chem. 2007 Jun 1;15(11):3801-17.